Submit
logo

ITI Pharma And Healthcare Fund - Regular Plan - IDCW Option

Category: Equity: Sectoral-Pharma and Healthcare Launch Date: 08-11-2021
AUM:

₹ 266.05 Cr

Expense Ratio

2.62%

Benchmark

Nifty Healthcare TRI

ISIN

INF00XX01BM3

Minimum Investment

5000.0

Minimum Topup

1000.0

Minimum SIP Amount

500

Fund Manager

Mr. Animesh Singh and Mr. Nilay Dalal

Fund Performance 1Y (%) 3Y (%) 5Y (%)
ITI Pharma And Healthcare Fund - Regular Plan - IDCW Option 5.03 17.25 -
NIFTY Healthcare TRI 7.63 20.42 13.45
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%

Overview

NAV
17.2087
Last change
0.34 (1.9589%)
Fund Size (AUM)
₹ 266.05 Cr
Performance
11.54% (Inception)

Asset Allocation

Equity

Debt

Others

Nav Movement

Investment Objective

The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. However, there can be no assurance that the investment objective of the scheme would be achieved.

Fund Manager
Mr. Animesh Singh and Mr. Nilay Dalal
Riskometer
Very High

Top 10 Holdings

Company Holdings (%)
SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- 11.96
DIVIS LABORATORIES LIMITED EQ NEW RS. 2/- 9.51
APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/- 5.45
Dr. Reddys Laboratories Ltd 4.78
TORRENT PHARMACEUTICALS LIMITED EQ NEW FV RS.5/- 4.78
MAX HEALTHCARE INSTITUTE LIMITED EQ 4.49
CIPLA LIMITED EQ NEW FV RS.2/- 4.19
LAURUS LABS LIMITED EQ NEW FV RS. 2/- 4.02
AUROBINDO PHARMA LIMITED EQ NEW F.V. RE.1/- 4.01
MANKIND PHARMA LIMITED EQ NEW FV RE. 1/- 3.78

Sector Allocation

Sector Holdings (%)
Healthcare 97.17
Capital Goods 1.22
Chemicals 0.92

Peer Comparison

Scheme Name 5Y (%)
ITI Pharma And Healthcare Fund Reg IDCW 0.0